Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers

Clinical Pharmacology and Therapeutics

Volumn 68, Issue 5, 2000, Pages 478-486

  Min, David I ^a   Lee, Miyoung ^a   Ku, Yi Min ^a   Flanigan, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE;

ADMINISTRATION, ORAL; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; CYCLOSPORINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; SEX FACTORS;

EID: 0033725192     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.111255     Document Type: Article

References (21)

1. Cyclosporine
2. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
3. P-glycoprotein and drug therapy in organ transplantation
4. Factors influencing the pharmacokinetics of cyclosporine in man
5. Clinical pharmacokinetics of cyclosporin
6. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability
7. Cyclosporine bioavailability: Dosing implications and impact on clinical outcomes in select transplantation subpopulations
8. Cyclosporine pharmacokinetics and variability from a microemulsion formulation-a multicenter investigation in kidney transplant patients
9. Effect of grapefruit juice on microemulsion cyclosporine and its metabolites pharmacokinetics in healthy volunteers: Does formulation difference matter?
10. Liquid-chromatographic determination of cyclosporine A in blood and plasma
11. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4
12. CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5'-promotor region polymorphism
13. Role of intestinal p-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
14. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient
15. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients
16. Ethnic differences in the pharmacokinetics of oral nifedipine
17. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood
18. Cyclosporine blood concentrations in the management of renal transplant recipients
19. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation
20. Efficacy of area under the curve cyclosporine monitoring in renal transplantation
21. Cyclosporine trough levels in predicting allograft rejection and renal toxicity at different time points after kidney transplantation